Early Bird Pricing ends September 2nd! Register soon to lock in the lowest registration cost!
Moffitt Cancer Center presents
2024 Cell Coast Conference
Join us for an exclusive, one-of-a-kind summit featuring updates on breakthroughs in research and treatment in the cell therapies space. Global thought leaders will share their perspectives on the current and future state of the liquid and solid tumor cell therapy landscape.
2024 Event Details
When: Friday October 25 - Sunday October 27, 2024
Where: The Don Cesar, 3400 Gulf Blvd, St. Pete Beach, FL
Who Should Attend the Summit?
The event is open to anyone interested in learning more about the current and future states of cell therapy treatments. Providers, researchers, and industry leaders are encouraged to attend.
Cell Coast Conference Learning Objectives
Critically evaluate the current landscape of cell therapy in hematologic malignancies, analyzing the latest clinical trial outcomes and evidence-based practices.
Explore innovative strategies and emerging technologies in cell therapy for solid tumors and hematologic malignancies, focusing on the development and application of novel cellular treatments.
Foster interdisciplinary collaboration between community oncologists, cell therapists, clinical investigators, and solid tumor disease experts, in order to increase access and accelerate translation of CAR-T, TIL, and other transformative cell therapies.
-
4:00pm - 5:00pm Faculty Meet and Greet
King Charles Lobby
-
7:00 pm Welcome Reception and Dinner
South Terrace, Don Cesar Resort
Sponsor: Kite Pharmaceuticals
Saturday October 26, 2024
-
8:00am - 8:30am Registration and Welcome Coffee/Breakfast and Exhibits
Sponsor: Amgen
Registration
Breakfast and Coffee provided
Exhibits Open
-
8:30am – 8:45am Opening Remarks by the conference chairpersons
Frederick Locke MD and Kedar Kirtane MD, Moffitt Cancer Center
-
8:45am – 10:15am Session 1: Cellular Therapies in Hematologic Malignancies
Session Chair: Michael Jain MD, PhD, Moffitt Cancer Center
8:45 am – 8:55 am Updates on Approved CAR-T for Lymphoma
Julio Chavez MD, Moffitt Cancer Center9:05 am – 9:15 am CAR-T for ALL
Bijal Shah, MD; Moffitt Cancer Center9:25 am – 9:35 am CAR-T Strategies for Multiple Myeloma
Krina Patel, MD, UT MD Anderson Cancer Center
9:45 am – 9:55 am Bi-specifics for Myeloma
Omar Castaneda-Puglianini, MD; Moffitt Cancer Center10:05 am – 10:15 am Cellular Therapies for Myeloid Malignancies
David Sallman MD; Moffitt Cancer Center -
10:25am – 10:45am Break and Exhibits
Sponsor: Pharma Essentials
-
10:45am – 12:15pm Session 2: Cellular Therapies in Solid Tumor Malignancies
Session Chair: Kedar Kirtane, MD, Moffitt Cancer Center
10:45am – 10:55am Melanoma TILS
Amod Sarnaik, MD; Moffitt Cancer Center11:05am – 11:15am Surgical Considerations for TIL Procurement
John Mullinax, MD, Moffitt Cancer Center11:25am – 11:35am Novel Cell Therapies for Thoracic Malignancies
Benjamin Creelan, MD, Moffitt Cancer Center
11:45am – 11:55pm Afami-cel TCR for Sarcoma
Brian Van Tine, MD, PhD, Washington University12:05 pm – 12:15 pm Intravesical TIL for Bladder Cancer
Michael Poch, MD, Moffitt Cancer Center -
12:30pm - 1:30pm Lunch & Exhibits
Lunch provided
-
1:30pm – 3:20pm Session 3: The Real World and the Future World for Cell Therapy
Session Chair: Frederick L. Locke MD, Moffitt Cancer Center
1:30 pm – 1:40 pm Point of Care CAR T Manufacturing
Natasha Kekre, BSc, MD, MPH, FRCPC, University of Ottawa1:50 pm – 2:00 pm Real World CAR-T for Multiple Myeloma
Doris Hansen, MD; Moffitt Cancer Center2:10 pm– 2:20 pm Infections Occurring in our ICE T Patient Population
Aliyah Baluch, MD; Moffitt Cancer Center2:30 pm – 2:40 pm CAR-T in Autoimmune Diseases
Sayeef Mirza, MD, MPH, Moffitt Cancer Center2:50 pm – 3:00 pm NK Cellular Therapies
Rizwan Romee, MD; Dana Farber Cancer Institute3:10 pm – 3:20 pm Future of TILs
Allison Betof Warner, MD, PhD, Stanford Medicine -
3:30pm – 3:45pm Break and Exhibits
Sponsor: Pharma Essentia
-
3:45pm – 5:00pm Session 4: Operational Readiness in the Community, Cell Therapy Center, and Beyond
Session Chair: Julio Chavez, MD; Moffitt Cancer Center
3:45 pm – 4:15 pm Interface of Community Oncologists and Academic Centers for Cellular Therapies
Mihaela Druta MD, Moffitt Cancer Center
Ciara Freeman MD, PhD Moffitt Cancer Center4:30 pm – 5:00 pm Business Operations of Cellular Therapies
Sunday October 27, 2024
-
8:00am Breakfast
Sponsor: Bristol Myers Squibb
Join Us for Breakfast on the Beach Pavilion
Immunotherapy Headlines
Meet the Speakers
The conference features experts in liquid and solid tumor cell therapy research and treatment. Here are a few of the confirmed speakers.
Frederick Locke, MD
Chair and Senior Member, BMT and Cellular Immunotherapy
Leader, Cellular Immunotherapy Program
Moffitt Cancer Center
Kedar Kirtane, MD
Associate Member, Department of Head and Neck-Endocrine Oncology
Moffitt Cancer Center
Aliyah Baluch, MD, MSC
Associate Member, Division of Infectious Disease, Department of Internal Medicine
Moffitt Cancer Center
Omar Castaneda-Puglianini, MD
Assistant Member, Department of Blood & Marrow Transplant & Cellular Immunotherapy
Moffitt Cancer Center
Julio Chavez, MD
Associate Member, Malignant Hematology
Medical Director, Clinical Research
Medical Director, Clinical Research
Moffitt Cancer Center
Ben Creelan, MD
Associate Member, Thoracic Oncology Department
Associate Professor, Dept. of Oncologic Sciences
Moffitt Cancer Center
Ciara Freeman, MD, MSc, PhD
Assistant Member, Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Doris Hansen, MD
Assistant Member, Department of Blood & Marrow Transplantation and Cellular Immunotherapy
Moffitt Cancer Center
Michael Jain, MD, PhD
Medical Director, Immune and Cellular Therapy Program
Associate Member, Clinical Investigator Track
Moffitt Cancer Center
Natasha Kekre, BSc, MD, MPH, FRCPC
Hematologist, Transplant and Cellular Therapy Program, Scientist, Clinical Epidemiology Program
University of Ottawa
Abu-Sayeef Mirza, MD, MPH
Assistant Member, Blood & Marrow Transplant & Cellular Immunotherapy
Moffitt Cancer Center
John Mullinax, MD
Associate Member with Tenure, Surgical Oncology, Section Chief, Surgical Oncology
Moffitt Cancer Center
Krina Patel, MD, MSc
Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas, MD Anderson Cancer Center
Michael Poch, MD
Course Co- Director; Assistant Member, Department of Genitourinary Oncology
Moffitt Cancer Center
Brian Van Tine, MD, PhD
Professor, Division of Oncology
Washington University School of Medicine in St. Louis